Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Costco Wholesale Corporation (COST) vs Stryker Corporation (SYK) Price & Performance

Costco Wholesale CorporationTrade
Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Costco Wholesale Corporation vs Stryker Corporation — how do they compare? Costco Wholesale Corporation trades at $946.92 (market cap $420.05B), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Costco Wholesale Corporation is far larger — about 4× Stryker Corporation's market cap, and Stryker Corporation pays the higher dividend (1.27%). Which is the better fit depends on your goals — on Pluang, investors hold Costco Wholesale Corporation for 133 Days and Stryker Corporation for 21 Days on average.

COSTSYK
Market Cap
$420.05B$106.24B
Volume
2,087,5652,982,001
Sector
Consumer StaplesHealth
52-Week High
$1.09K$388.35
52-Week Low
$849.63$269.75
Typical Hold Time
133 Days21 Days
Enterprise Value
$407.33B$117.70B
Dividend Yield
0.62%1.27%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Costco Wholesale Corporation

Costco (COST) trades at $947.92, up 0.6% with strong technical momentum. The stock shows robust fundamentals with revenue growth from $275.24B in 2025 to projected $303.2B in 2026 and improving net margins. Recent March sales surged 11.3% year-over-year, while analyst consensus remains strongly bullish with 66% buy ratings and a $1,100 price target. Technical indicators show bullish moving averages but overbought RSI levels near resistance at $954.

Outlook remains positive given membership fee increases and expansion potential, though high valuation multiples (P/E 45.66) pose risk if growth slows. Key risks include competitive pressures and economic sensitivity. Institutional accumulation continues with multiple advisors increasing positions in Q4 2025, supporting the bullish thesis.

Stryker Corporation

Stryker (SYK) trades at $276.97, up 0.57% today, amid a bearish technical signal with key support at $274 and resistance at $279. The company reported strong profitability with a 14.43% net income margin and beat Q2 2026 EPS estimates, though it missed in Q1. Recent news highlights ongoing legal scrutiny related to manufacturing issues disclosed in September 2026, which caused a significant share price drop.

Analyst consensus remains strongly bullish with a $368.11 price target, but risks include persistent manufacturing problems and potential securities litigation. Earnings growth and margin expansion support the long-term outlook, though near-term volatility may persist pending Q3 2026 results on October 29, 2026.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

COST
31% Buy69% Sell
Avg holding period · 133 Days
SYK

No sentiment data available yet.

Top news

Latest headlines on both assets

About Costco Wholesale Corporation

The leading warehouse club, Costco has 815 stores worldwide (at the end of fiscal 2021), with most sales derived in the United States (72%) and Canada (14%). It sells memberships that allow customers to shop in its warehouses, which feature low prices on a limited product assortment. Costco mainly caters to individual shoppers, but roughly 20% of paid members carry business memberships. Food and sundries accounted for 40% of fiscal 2021 sales, with non-food merchandise 29%, warehouse ancillary and other businesses (such as fuel and pharmacy) nearly 17%, and fresh food 14%. Costco's warehouses average around 146,000 square feet

Read more on COST →

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

Read more on SYK →